Dean Y. Li - Apr 30, 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Executive VP & President, MRL
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Dean Y. Li
Stock symbol
MRK
Transactions as of
Apr 30, 2024
Transactions value $
$0
Form type
4
Date filed
5/2/2024, 04:17 PM
Previous filing
Apr 3, 2024
Next filing
Jun 5, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 46.4K Apr 30, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +65.6K $0.00 65.6K Apr 30, 2024 Common Stock 65.6K $129.22 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.